health news arrowHome >> Children's Health >> Premie Breathing Treatment Not Harmful, Study Finds Fri, 29 Aug 2008 GMT 
health news
  NEWS YOU CAN TRUST

Search Health News 
Browser Preferences
 Add to Favorites

Main Menu
 Home
 - - - - - Hot Topics - - - - -
 Bird Flu
 Drug Safety
 Stem Cell Research
 - - - - - - - - - - - - - - - - -
 Alternative Medicine
 Children's Health
 Diet & Nutrition
 Disabilities
 *Diseases & Conditions
 Drugs & Herbs
 Environmental Health
 Fitness & Exercise
 Genetic Research
 Health Insurance
 Medical Ethics
 Men's Health
 *Mental Illness
 Pain
 Parenting
 Public Health & Safety
 Senior Care
 *Sexual Health
 Women's Health
 World Health
 - - - - - - - - - - - - - - - -
 Web Links
 Contact Us: info@dailynewscentral.com

XML News Feeds


 

HEALTH NEWS

Premie Breathing Treatment Not Harmful, Study Finds

PDF  Print  E-mail
 03 April, 2006  00:04 GMT

CNEP continuous nevative extrathoracic pressure
A long-term study that included some premature babies given continuous negative-extrathoracic pressure (CNEP) and some who got standard breathing tubes suggests no evidence of disadvantage, in terms of long-term disability or psychological outcomes, in the CNEP group.
A treatment to help premature babies breathe does not cause long-term harm as previously thought, a British study found.

University of Nottingham researchers followed up on 133 of the 205 children still alive -- now ages 9 to 15 -- who were involved in the original study on continuous negative-extrathoracic pressure, or CNEP, pioneered by pediatrician David Southall, the BBC reported Friday.

Pressure Applied to the Chest

Half the children had had the CNEP treatment -- with pressure applied to the chest to aid breathing -- but the rest were given the standard treatment of a breathing tube inserted through the larynx.

The researchers found no differences between the two groups of children, except those that could be explained by chance, and there was no evidence of a higher risk of long-term disability for children given CNEP.

Our long-term study of the original trial participants suggests no evidence of disadvantage, in terms of long-term disability or psychological outcomes, from the use of CNEP, said study leader Neil Marlow of Queen's Medical Center in London.




Related Articles
Deaths Caused by Prematurity Undercounted (2 Oct 2006)
C-Section Babies May Have Increased Allergy Risk (21 Oct 2004)
Firm Marketing Donor Breast Milk to Treat Premies (6 Aug 2005)
Inducing Labor at 32 Weeks Can Prevent Infections (11 Feb 2005)
Extremely Premature Babies Often Face a Lifetime of Disability (7 Jan 2005)
Anger, Fear, Sudden Movement May Trigger Stroke (14 Dec 2004)
 
Sponsored Text Links
SkinStore.com: Strivectin SD 6oz Best Price Offer
InsureMe.com: Click here to get a free health insurance quote.
Hydroderm: Body Shape - Proven to be safe and effective - Free Trial!
SkinStore.com: StriVectin-SD
Hydroderm: Lose wrinkles with Hydroderm